Filament Health (OTC:FLHLF) Stock, Quote.Headers.trade-ideas

Filament Health Corp is a natural psychedelic drug development company. Its mission is to see safe, approved, natural psychedelics in the hands of everyone who needs them as soon as possible. The group engages in natural extraction technology commercialization, utilizing its intellectual property portfolio, in-house GMP facility, and Health Canada psilocybin Dealer's License.

Psyched New - option 1

Biotech

Cannabis

Psychedelics

AWKNF

BETRF

CMND

FLHLF

MASSIVE INTERACTIVE NV by Massive Interactive, Inc.

HUGE

MDXXF

MNMD

OPTHF

RED LIGHT HOLLAND CORP by Red Light Holland Corp.

TRUFF

Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans&#39; Trips And More

News

CMPS

CYBN

SILO

Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More

Legal

Management

Events

Global

BRAXF

SILFF

Psychedelics Headlines: Predicting Readiness, Correcting The Hype, Good And Bad Drugs, Training Programs And More

FILAMENT HEALTH CORP by Filament Health Corp.

Filament Health Corp

Trilogy Metals Announce The Positive Results Of Its Preliminary Economic Assessment Study Or The Bornite Copper Project In The Ambler Mining District Of Northwestern Alaska

Parsons Announced That It Has Initiated A Task Order Extension Supporting The San Diego Pure Water Program

Arthur Hayes, co-founder of cryptocurrency exchange&nbsp;BitMEX&nbsp;and Chief Investment Officer at&nbsp;Maelstrom&nbsp;Fund, stated that Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) will thrive regardless of any government support or regulatory clarity under the incoming Donald Trump administration.
What Happened: In an interview with Benzinga, Hayes questioned the narrative that cryptocurrency-friendly regulations will serve as a bullish catalyst for the market
&#8220;Remember that we got to a total cryptocurrency market cap of over $3 trillion with no government support anywhere in the world. Why do we need it now?&#8221; Hayes argued.
As for Bitcoin, Hayes said that the leading cryptocurrency will flourish in spite of any regulations that would be enacted by Trump.
See Also:<a href="https://www.benzinga.com/24/12/42735744/pharma-bro-martin-shkreli-predicts-doom-for-michael-saylors-microstrategy-as-stock-dips-below-300-in-after-hours-trading"> </a><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42936962/shytoshi-kusama-outlines-treat-tokens-usefulness-ahead-of-launch-optimistic-whales-buy-up-shiba-inu">Shytoshi Kusama Outlines TREAT Token&#8217;s Usefulness Ahead Of Launch, Optimistic Whales Buy Up Shiba Inu</a>
Hayes expressed doubt on potential cryptocurrency-friendly policies under Trump, saying that most of them will only benefit his lobbyists and close advisors.
&#8220;I fear that the crypto regulation that Trump enacts will be a Frankenstein bill that is an inchoate mishmash of different policies desired by this or that close advisor or large campaign donor,&#8221; he said.
&#8220;It will be a gift to lobbyists and lawyers and will not ultimately bring that much clarity, as it will be impossible to comply with unless you have hundreds of millions of dollars to spend on lawyers.&#8221;
Hayes has been a long-time Bitcoin bull, projecting the apex cryptocurrency to hit $1 million in the long term. 
Why It Matters: Hayes&#8217; remarks come at a time when the incoming Trump administration is expected to significantly alter the landscape of cryptocurrency regulation. 
Recent reports suggested that Trump could issue <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42962279/trump-could-sign-crypto-related-executive-orders-on-day-1-report">executive orders on day one of his presidency</a>, possibly addressing de-banking and&nbsp;<a href="https://www.benzinga.com/24/12/42502213/new-crypto-accounting-standards-from-todaywill-it-boost-bitcoins-corporate-adoption" target="_blank" rel="noreferrer noopener">fair value accounting</a>, which requires banks holding cryptocurrencies to count them as liabilities on their balance sheet.
Trump has rewarded supporters with high-level appointments in the incoming administration. He named venture capitalist David Sacks, who held a <a href="https://www.benzinga.com/24/12/42356067/venture-capitalist-david-sacks-appointed-as-white-house-ai-crypto-czar-by-trump">fundraising event for Trump&#8217;s campaign</a> at his home, as the &#8220;White House A.I. &amp; Crypto Czar.&#8221;
Price Action: At the time of writing, Bitcoin was exchanging hands at $93,573.37, down 0.90% in the last 24 hours, according to&nbsp;<a href="https://pro.benzinga.com/dashboard" target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42935597/mark-cuban-advocates-bitcoin-over-gold-during-economic-turmoil-i-think-it-has-more-value-than-gold">Mark Cuban Advocates Bitcoin Over Gold During Economic Turmoil: &#8216;I Think It Has More Value Than Gold&#8217;</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Government

Regulations

Exclusives

Markets

$BTC

MSTR

Trump's Crypto Legislation Will Be A 'Frankenstein' Bill Of Mishmash, Says Arthur Hayes — Bitcoin Doesn't Need Government Support To Flourish

TD Securities analyst Aaron Macneil initiates coverage on Enbridge (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ENB#TSX">ENB</a>) with a Buy rating and announces Price Target of C$66.

Price Target

Initiation

Analyst Ratings

TSX:ENB

TD Securities Initiates Coverage On Enbridge with Buy Rating, Announces Price Target of C$66

Needham analyst Chris Pierce reiterates Solid Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLDP#NASDAQ">SLDP</a>) with a Buy and maintains $2 price target.

Reiteration

SLDP

Needham Reiterates Buy on Solid Power, Maintains $2 Price Target

Needham analyst Tom Nikic reiterates On Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>) with a Buy and maintains $64 price target.

ONON

Needham Reiterates Buy on On Holding, Maintains $64 Price Target

TD Securities analyst Aaron Macneil initiates coverage on Pembina Pipeline (TSX:<a class="ticker" href="https://www.benzinga.com/stock/PPL#TSX">PPL</a>) with a Buy rating and announces Price Target of C$66.

TSX:PPL

TD Securities Initiates Coverage On Pembina Pipeline with Buy Rating, Announces Price Target of C$66

TD Securities analyst Aaron Macneil initiates coverage on South Bow (TSX:<a class="ticker" href="https://www.benzinga.com/stock/SOBO#TSX">SOBO</a>) with a Hold rating and announces Price Target of C$34.

TSX:SOBO

TD Securities Initiates Coverage On South Bow with Hold Rating, Announces Price Target of C$34

On Tuesday, January 14th, U.S. markets closed mixed, with the S&amp;P 500 edging higher and the Nasdaq slipping after a volatile session. Investors evaluated inflation data and prepared for quarterly earnings reports. The producer price index rose less than expected, while elevated Treasury yields and uncertainty surrounding Federal Reserve policy fueled caution. Earnings season kicks off Wednesday, led by major banks.
According to economic data, U.S. producer prices increased by 0.2% in December, down from 0.4% in November, and below market expectations of a 0.3% rise.
Most S&amp;P 500 sectors rose, led by utilities, materials, and financials, while communication services and healthcare declined.
The Dow Jones Industrial Average was up 0.52% and closed at 42,518.28, the S&amp;P 500 closed higher by 0.11% at 5,842.91, while the Nasdaq Composite slid 0.23% to finish at 19,044.39.
Big banks are supposed to kick off the fourth-quarter earnings season today.
Aisa Markets Today
<ul>
<li>On Wednesday, Japan&#8217;s Nikkei 225 closed higher by 0.09% at 38,471.50, led by gains in the Transportation Equipment, Chemical, Petroleum &amp; Plastic and Insurance sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 fell 0.22%, ending the session at 8,213.30, led by losses in the IT, Telecoms Services, and Industrials sectors.</li>
<li>India&#8217;s Nifty 50 closed higher by 0.23% at 23,228.55, and the Nifty 500 gained 0.36%, closing at 21,558.75, led by gains in the Power, Real Estate, and Technology sectors.</li>
<li>China&#8217;s Shanghai Composite fell 0.43% and closed at 3,227.12, and the Shenzhen CSI 300 slid 0.64%, finishing the day at 3,796.03.</li>
<li>Hong Kong Hang Seng closed the session higher by 0.34% at 19,286.07.</li>
</ul>
Eurozone at 06:00 AM ET
<ul>
<li>The European STOXX 50 was up 0.36%.</li>
<li>Germany&#8217;s DAX gained 0.67%.</li>
<li>France&#8217;s CAC rose 0.36%.</li>
<li>U.K.&#8217;s FTSE index 100 traded higher by 0.74%.</li>
</ul>
Commodities at 06:00 AM ET
<ul>
<li>Crude Oil WTI was trading higher by 0.21% at $76.57/bbl, and Brent was up 0.15% at $80.04/bbl.</li>
<li>Natural Gas gained 0.78% to $3.999.</li>
<li>Gold was trading higher by 1.05% at $2,710.76, Silver was up 1.32% to $30.750, and Copper rose 0.10% to $4.3470.</li>
</ul>
U.S. Futures at 06:00 AM ET
Dow futures were up 0.19%, S&amp;P 500 futures rose 0.16% and Nasdaq 100 futures gained 0.21%.
Forex at 06:00 AM ET
<ul>
<li>The U.S. Dollar Index fell 0.11% to 109.06, USD/JPY declined 0.72% to 156.80, and USD/AUD slid 0.14% to 1.6119.</li>
<li>Global stocks rose cautiously ahead of U.S. inflation data and bank earnings, while bond yields dipped. December&#8217;s tame producer price data eased pressure on Treasuries.</li>
</ul>
Photo by Pavel Bobrovskiy via Shutterstock

Asia

Emerging Markets

Eurozone

Futures

Commodities

Forex

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Dollar Cools Off Ahead Of Bank Earnings, Asia Markets Mixed, Europe Up - Global Markets Today While US Slept

Needham analyst Chris Pierce reiterates Blink Charging (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLNK#NASDAQ">BLNK</a>) from Buy to Buy.

BLNK

Needham Reiterates Buy on Blink Chargingto Buy

The Company expects to meet its net revenue, adjusted EBITDA, and adjusted diluted EPS guidance, exceed its operating cash flow guidance, and exceed (incur less than) its capital expenditures guidance. The Company also intends to announce that it estimates its net leverage as of December 31, 2024 to be approximately 4x.

Guidance

AMRX

Amneal Pharmaceuticals Expects To Meet Its 2024 Net Revenue, Adjusted EBITDA, And Adjusted EPS Guidance, Exceed Its Operating Cash Flow Guidance - Filing

Needham analyst James Ricchiuti reiterates Advanced Energy Indus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEIS#NASDAQ">AEIS</a>) with a Buy and maintains $145 price target.

AEIS

Needham Reiterates Buy on Advanced Energy Indus, Maintains $145 Price Target

JP Morgan analyst Michael Rehaut maintains KB Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBH#NYSE">KBH</a>) with a Neutral and lowers the price target from $82 to $74.5.

JP Morgan Maintains Neutral on KB Home, Lowers Price Target to $74.5

Needham analyst James Ricchiuti reiterates 3D Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDD#NYSE">DDD</a>) from Hold to Hold.

Needham Reiterates Hold on 3D Systo Hold

Compass Point analyst Floris Van Dijkum initiates coverage on Curbline Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CURB#NYSE">CURB</a>) with a Neutral rating and announces Price Target of $24.

CURB

Compass Point Initiates Coverage On Curbline Properties with Neutral Rating, Announces Price Target of $24

Needham analyst James Ricchiuti reiterates MKS Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKSI#NASDAQ">MKSI</a>) with a Buy and maintains $156 price target.

MKSI

Needham Reiterates Buy on MKS Instruments, Maintains $156 Price Target

Needham analyst John Todaro reiterates Applied Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) with a Buy and maintains $11 price target.

APLD

Needham Reiterates Buy on Applied Digital, Maintains $11 Price Target

CIBC analyst Hamir Patel upgrades Weyerhaeuser (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WY#NYSE">WY</a>) from Neutral to Outperformer and announces $35 price target.

Upgrades

CIBC Upgrades Weyerhaeuser to Outperformer, Announces $35 Price Target

For the twelve months ended December 31, 2024, Unity Bancorp reported net income of $41.5 million, or $4.06 per diluted share, compared to net income of $39.7 million, or $3.84 per diluted share, for the twelve months ended December 31, 2023. This represents a 4.4% increase net income and a 5.7% increase in net income per diluted share.

Unity Bancorp Reports Q4 EPS Of $1.13 Compared With $1.07 YoY, Which Represents 1.83% ROA And 15.77% ROE

GXO Logistics, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GXO#NYSE">GXO</a>) teamed up with The Perfume Shop, one of the <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/g42995528/the-perfume-shop-partners-with-gxo-for-high-street-deliveries" rel="noreferrer noopener">largest fragrance retailers in the U.K</a>.
The deal entails GXO providing weekly deliveries to over 200 stores via its shared transport network.
Notably, GXO&#8217;s shared transport network consolidates deliveries for multiple retailers, significantly reducing vehicle trips to crowded city centers.
Each vehicle typically carries goods from five different customers and stops at 8 to 10 locations, improving efficiency compared to dedicated delivery services.
Shared transport can cut CO2 emissions by up to 5kg per litre when compared to underutilized dedicated vehicles.
Additionally, this model helps reduce urban congestion, aligning with city policies aimed at lowering emissions and promoting sustainable transportation.
Last week, the company inked a long-term partnership <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/g42894129/gxo-signs-a-new-partnership-with-calliope-in-italy" rel="noreferrer noopener">with </a><a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/g42894129/gxo-signs-a-new-partnership-with-calliope-in-italy" rel="noreferrer noopener">Calliope</a><a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/g42894129/gxo-signs-a-new-partnership-with-calliope-in-italy" rel="noreferrer noopener"> in Italy</a>.
The contract comprises providing warehouse management, e-fulfillment, returns handling, and value-added services like labeling and quality control.
Investors can gain exposure to the stock via Tidal ETF Trust Aztlan North America Nearshoring Stock Selection ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRSH#NYSE">NRSH</a>) and Invesco S&amp;P Spin-Off ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSD#NYSE">CSD</a>).
Price Action: GXO shares closed higher by 1.59% at $43.55 on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/42994950" target="_blank" rel="noreferrer noopener">Nippon Steel Eyes Trump Administration To Revive $15B US Steel Deal Blocked By Biden: &#8216;We&#8217;ll Do Whatever It Takes&#8217;</a></li>
</ul>
Image via Shutterstock.

Equities

Mid Cap

Contracts

NRSH

GXO Logistics Partners with The Perfume Shop For Sustainable Deliveries Across 200 UK Stores: Details

Filament Health reports FY results

Filament Health reports Q1 results

Filament Health reports Q2 results

Filament Health reports Q3 results

Press Releases

Elaine Elisabetsky, PhD, Member of Jaguar Health's Mental Health Entheogen Therapeutics Initiative, to Speak August 2nd About Plant-Based Medicines Used to Manage Schizophrenia at the University of Illinois Chicago College of Pharmacy

Small Cap

FILAMENT HEALTH ANNOUNCES MAJOR INTELLECTUAL PROPERTY EXPANSION

Earnings

FILAMENT HEALTH ANNOUNCES SECOND QUARTER 2024 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

Key Collaborator of Jaguar Health Joint Venture Magdalena Biosciences Receives Prestigious Alzheimer's Association Award

FILAMENT HEALTH ANNOUNCES ISSUANCE OF COMMON SHARES TO NEGEV CAPITAL INVESTMENTS LIMITED PURSUANT TO ADVISORY AGREEMENT

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present October 16 at BIO Investor Forum

FILAMENT HEALTH ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

FILAMENT HEALTH ANNOUNCES IMPORT OF COCA LEAF FROM PERU BY JOINT VENTURE MAGDALENA BIOSCIENCES

Jaguar Health Announces Import of Coca Leaf From Peru by Joint Venture Magdalena Biosciences for Research in Treating Mental Health Indications

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present January 12 at the Annual Neuroscience Innovation Forum

JAGX

Filament Health

Comments

Filament Health

Filament Health (FLHLF) Forecast

Filament Health (OTC:FLHLF) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga